Day: April 16, 2025

MINNEAPOLIS, April 16, 2025 (GLOBE NEWSWIRE) — PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) (“PetVivo”), an emerging biomedical device company focused on the commercialization of innovative medical devices and other therapeutics for equine and companion animals, announced today it has entered into a definitive distribution agreement with Eq Especialidades (“Eq Especialidades”). Eq Especialidades will inventory, market and promote PetVivo’s veterinary medical device, Spryng™ with OsteoCushion™ technology, throughout Mexico. Eq Especialidades sales and marketing activities will commence on April 1, 2025. SPRYNG® with OsteoCushion® Technology, is an intra-articular injectable veterinary medical device consisting of sterilized, extra-cellular matrix microparticles. The microparticles of Spryng have...

On 16 April 2025 the Supervisory Board of AS Tallink Grupp approved the audited annual report for 2024 and will submit it to the General Meeting of Shareholders for approval. Compared to the unaudited interim report published on February 20 there are no differences in the audited annual report in terms of the financial results. The audited annual report of AS Tallink Grupp for the financial year 2024 in ESEF format together with the independent auditor’s report is attached to this release and will be made available on the website of AS Tallink Grupp at https://company.tallink.com/for-investors/reports-and-financial-key-figures. In the financial year 2024 (1 January – 31 December), AS Tallink Grupp and its subsidiaries (the Group) carried 5.6 million passengers, which is down 2.2% compared to the financial year 2023. The number of cargo...

On 16 April 2025 the Supervisory Board of AS Tallink Grupp approved the audited annual report for 2024 and will submit it to the General Meeting of Shareholders for approval. Compared to the unaudited interim report published on February 20 there are no differences in the audited annual report in terms of the financial results. The audited annual report of AS Tallink Grupp for the financial year 2024 in ESEF format together with the independent auditor’s report is attached to this release and will be made available on the website of AS Tallink Grupp at https://company.tallink.com/for-investors/reports-and-financial-key-figures. In the financial year 2024 (1 January – 31 December), AS Tallink Grupp and its subsidiaries (the Group) carried 5.6 million passengers, which is down 2.2% compared to the financial year 2023. The number of cargo...

Coop Pank invites shareholders, investors, analysts and other stakeholders to join its investor webinar, scheduled on 23 April 2025 at 9 am (EET). The webinar will be held in Estonian. The webinar will be hosted by the Chairman of the Board Margus Rink and the Chief Financial Officer Paavo Truu, who present the unaudited financial results of the First Quarter of 2025. During the webinar all attendees can ask questions. All questions will be answered after the presentation. To join the webinar, you need to register in advance via following link: https://bit.ly/CP-veebiseminar-osalemine-23042025   Registrants will be sent a link to the webinar and a reminder email one hour before the start of the webinar. The webinar will be recorded and published on the company’s website www.cooppank.ee and on our YouTube account. Coop Pank, based...

NOTICE OF 2025 ANNUAL GENERAL MEETINGShell plc’s 2025 Annual General Meeting (“AGM”) scheduled to be a hybrid meeting, facilitating both physical and virtual attendance Shareholders encouraged to vote in advance of the AGM, but voting enabled during the meeting for those formally in attendanceToday, Shell plc (the “Company”) posted its Notice of 2025 Annual General Meeting (the “Notice”), which can be viewed and downloaded from shell.com/agm. The AGM is scheduled to be held at the Sofitel London Heathrow Hotel – Terminal 5, London Heathrow Airport, London TW6 2GD at 10:00 (UK time) on Tuesday May 20, 2025. Further details on how to join or watch the AGM can be found within the Notice. National Storage MechanismIn accordance with the UK Listing Rules, a copy of each of the documents below is being submitted to the National Storage...

ATHENS, Greece, April 16, 2025 (GLOBE NEWSWIRE) — Performance Shipping Inc. (NASDAQ: PSHG), (“we” or the “Company”), a global shipping company specializing in the ownership of tanker vessels, announced that it has filed its 2024 Annual Report on Form 20-F for the fiscal year ended December 31, 2024 (the “Annual Report”), with the U.S. Securities and Exchange Commission (the “SEC”). The Annual Report, which contains the Company’s audited consolidated financial statements, can be accessed through the SEC’s website at http://www.sec.gov as well as through the Company’s website at http://www.pshipping.com. Upon request, we will provide any shareholder with a hard copy of the Annual Report free of charge. About the Company Performance Shipping Inc. is a global provider of shipping transportation services through its ownership...

BEIJING, April 16, 2025 (GLOBE NEWSWIRE) — Kingsoft Cloud Holdings Limited (“Kingsoft Cloud” or the “Company”) (NASDAQ: KC and HKEX: 3896), a leading cloud service provider in China, today announced the pricing of its underwritten public offering (the “Public Offering”) of 18,500,000 of American depositary shares (the “ADSs”), each representing 15 ordinary shares of the Company, at a price of US$11.27 per ADS or a total of 277,500,000 ordinary shares at a price of HK$5.83 per ordinary share, based upon each ADS representing 15 ordinary shares and an exchange rate of HK$7.7574 to US$1.00, the spot rate of exchange at the time of pricing. All ADSs will be offered by Kingsoft Cloud. Investors have an option to receive ordinary shares of the Company to be traded on the HKEX (the “Shares”) in lieu of ADSs in this offering. Subject to...

Live moderated webcast with members of the Senti Bio management team on Wednesday, April 23rd at 4:00 PM ET SOUTH SAN FRANCISCO, Calif., April 16, 2025 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that will participate in the Virtual Investor Closing Bell Series on Wednesday, April 23, 2025 at 4:00 PM ET. As part of the event, Timothy Lu, MD, PhD, Chief Executive Officer and Co-Founder, and Kanya Rajangam, MD, PhD, President, Head of R&D and Chief Medical Officer, of Senti Bio will provide a corporate overview. In addition to the moderated discussion, there will be a live question and answer session. The Company will answer as many...